tiprankstipranks
Trending News
More News >
Omega Diagnostics Group PLC (DE:RVKA)
FRANKFURT:RVKA

Omega Diagnostics (RVKA) Price & Analysis

Compare
0 Followers

RVKA Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

0.08%99.92%
Mutual Funds
― Other Institutional Investors
99.92% Public Companies and
Individual Investors

RVKA FAQ

What was Omega Diagnostics Group PLC’s price range in the past 12 months?
Omega Diagnostics Group PLC lowest stock price was €0.02 and its highest was €0.05 in the past 12 months.
    What is Omega Diagnostics Group PLC’s market cap?
    Omega Diagnostics Group PLC’s market cap is £8.93M.
      When is Omega Diagnostics Group PLC’s upcoming earnings report date?
      Omega Diagnostics Group PLC’s upcoming earnings report date is Jul 22, 2025 which is in 37 days.
        How were Omega Diagnostics Group PLC’s earnings last quarter?
        Omega Diagnostics Group PLC released its earnings results on Nov 21, 2024. The company reported €0 earnings per share for the quarter, the consensus estimate of N/A by €0.
          Is Omega Diagnostics Group PLC overvalued?
          According to Wall Street analysts Omega Diagnostics Group PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Omega Diagnostics Group PLC pay dividends?
            Omega Diagnostics Group PLC does not currently pay dividends.
            What is Omega Diagnostics Group PLC’s EPS estimate?
            Omega Diagnostics Group PLC’s EPS estimate is >-0.01.
              How many shares outstanding does Omega Diagnostics Group PLC have?
              Omega Diagnostics Group PLC has 237,950,650 shares outstanding.
                What happened to Omega Diagnostics Group PLC’s price movement after its last earnings report?
                Omega Diagnostics Group PLC reported an EPS of €0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went down -10%.
                  Which hedge fund is a major shareholder of Omega Diagnostics Group PLC?
                  Currently, no hedge funds are holding shares in DE:RVKA

                  Company Description

                  Omega Diagnostics Group PLC

                  Cambridge Nutritional Sciences plc, through its subsidiaries, develops, manufactures, and distributes medical diagnostics products for the food sensitivity testing market. The company is involved in the research, development, and production of kits for detection of immune reactions to food under the Foodprint name. It provides clinical analysis to the general public, clinics, and health professionals, as well as supplies Food Detective, a consumer food test. The company serves government, private hospitals, reference laboratories, nutritionists, naturopaths, and other healthcare professionals. Cambridge Nutritional Sciences plc operates in the United Kingdom, rest of Europe, North America, South/Central America, India, other Asian countries and the Far East, Africa, and the Middle East. The company was formerly known as Omega Diagnostics Group PLC and changed its name to Cambridge Nutritional Sciences plc in September 2023. Cambridge Nutritional Sciences plc was founded in 1987 and is based in London, the United Kingdom.
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  RUA Life Sciences
                  EKF Diagnostics Holdings
                  Feedback
                  Cizzle Biotechnology Holdings PLC
                  Tristel
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis